Jeff Chodakewitz

Dr. Chodakewitz has served as a member of the board of directors since April 2021. Dr. Chodakewitz has more than 30 years of management experience in the biopharmaceutical industry. Most recently he served as the Chief Medical Officer and Executive Vice President, Global Medicines Development & Medical Affairs at Vertex Pharmaceuticals. Prior to Vertex, Dr. Chodakewitz spent over 20 years at Merck & Co. serving in several positions, including leadership roles as Head of Infectious Diseases and Vaccines Global Development, Senior Vice President of Global Scientific Strategy (infectious disease, respiratory & immunology), Vice President of Early-Stage Development and Senior Vice President of Late-Stage Development. Dr. Chodakewitz currently serves on the boards of directors of Adicet Bio (NASDAQ: ACET), Freeline Therapeutics (NASDAQ: FRLN), and Schrödinger (NASDAQ: SDGR). Dr. Chodakewitz received a B.S. in Biochemistry cum laude from Yale University and an M.D. from the Yale University School of Medicine.